US2006104995A1PendingUtilityA1
Methods for treating headache
Est. expiryFeb 26, 2024(expired)· nominal 20-yr term from priority
A61P 43/00A61P 25/00A61P 25/08A61P 25/30A61P 29/00A61P 25/06A61K 9/0019A61K 38/4893C12Y 304/24069A61K 39/08A61K 38/48
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention features a method for treating a headache in an acute pain medication overuse patient. In some embodiments, the method comprises the step of local administration of a botulinum toxin to a patient who is an acute pain medication overuse patient, thereby both countering a headache exacerbation caused by the acute pain medication overuse and reducing the use of the acute pain medication by the patient to treat a headache.
Claims
exact text as granted — not AI-modified1 . A method for treating a headache in an acute pain medication overuse patient, the method comprising the step of local administration of a botulinum toxin to the patient, thereby both countering a headache exacerbation caused by the acute pain medication overuse and reducing the use of the acute pain medication by the patient to treat the headache.
2 . The method of claim 1 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.
3 . The method of claim 1 , wherein the botulinum toxin is a botulinum toxin type A.
4 . The method of claim 1 , wherein the botulinum toxin is administered in an amount of between about 1 unit and about 10,000 units.
5 . The method of claim 1 , wherein the local administration is by intramuscular or subcutaneous administration to a location on or within a head of a patient.
6 . The method of claim 1 , wherein the local administration of the botulinum toxin is to a facial muscle of the patient.
7 . The method of claim 1 , wherein the local administration is to a forehead of the patient.
8 . The method of claim 1 , wherein the local administration of the botulinum toxin is to a subdermal location or to a muscle location from which the patient perceives a pain to arise.
9 . A method for treating a headache in an acute pain medication overuse patient, the method comprising the step of local administration of between about 1 unit and about 1,500 units of a botulinum toxin type A to the patient, thereby both countering a headache exacerbation caused by the acute pain medication overuse and reducing the use of the acute pain medication by the patient to treat the headache.
10 . A method for increasing the effectiveness of an acute pain medication to treat a headache, the method comprising the step of administering an acute pain medication to treat a headache and local administration of a botulinum toxin, whereby the effectiveness of the acute pain medication is increased.
11 . The method of claim 10 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.
12 . The method of claim 10 , wherein the botulinum toxin is a botulinum toxin type A.
13 . The method of claim 10 , wherein the botulinum toxin is administered in an amount of between about 1 unit and about 10,000 units.
14 . The method of claim 10 , wherein the local administration is by intramuscular or subcutaneous administration to a location on or within a head of a patient.
15 . The method of claim 10 , wherein the local administration of the botulinum toxin is to a facial muscle of the patient.
16 . The method of claim 10 , wherein the local administration is to a forehead of the patient
17 . The method of claim 10 , wherein the local administration of the botulinum toxin is to a subdermal location or to a muscle location from which the patient perceives a pain to arise.
18 . A method for increasing the effectiveness of an acute pain medication to treat a headache, the method comprising the step of administering an acute pain medication and local administration of between about 1 unit and about 1,500 units of a botulinum toxin type A, thereby increasing the effectiveness of the acute pain medication to treat a headache.
19 . The method of claim 1 or 10 wherein the headache is a chronic daily headache.Join the waitlist — get patent alerts
Track US2006104995A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.